All the the technologies were developed in order to find substances that can reset the epigenetic program of cells and organism in order to attack cancer with their misguided epigenome at the epigenetic level. Our first development, compound QE2019-1 shows unprecedented success in treating the diseases AML and MDS in mouse xenograft models.

The proprietary QuGen epigenetic analysis technologies have the ultimate goal to develop substances and life styles that keeps your epigenome in order for a longer, more healthy life. A deep analysis of your epigenome allows us to determine your cellular age. Adjusting your life style while monitoring your epigenome puts you into a position to reduce your speed of ageing and even to revert epigenetic aging marks. We at QuGen develop substances that control ageing. We rejuvenate healthy but aged cells and we send malignant cancer cells into an increased aging process for self-destruction even of the most aggressive tumor cells. Our first anticancer substance Qucitabine shows in pre-clinical animal models superior anticancer effects (in AML and MDS) and breaks even resistances, proving that the concept to control aging is a successful novel avenue to cure cancer and to rejuvenate cells.